Most traditional magnesium forms, such as glycinate or citrate, struggle to cross the blood-brain barrier, often failing to reach the brain in concentrations necessary to impact cognitive function. Mental Magnesium attempts to solve this via a dual-action approach. Magtein, labeled as 'The Builder,' is designed to elevate brain magnesium levels and support synaptic connections, while ATA Mg serves as 'The Balancer,' utilizing a lipophilic pathway to modulate neural signals through kainate and NMDA receptors.
Triquetra Health Debuts Dual-Pathway Magnesium for Cognitive Support
Austin-based supplement firm Triquetra Health has launched Mental Magnesium, a cognitive health formula that integrates two patented magnesium compounds. By combining Magtein and ATA Mg, the product aims to bypass the blood-brain barrier to deliver magnesium directly to neural tissues, addressing a common limitation in standard supplement formulations.
Founder and CEO Sean Gill notes that standard supplements often stop at the bloodstream, leaving the brain underserved. To address this, the new formula includes 1,000 mg of Magtein and 450 mg of ATA Mg, alongside cofactors like Vitamin D3 and Pyridoxal-5'-Phosphate. The product is supported by clinical research, including trials suggesting cognitive performance improvements and safety evaluations by the EFSA. Currently manufactured in cGMP-certified facilities, the supplement is available on Amazon, targeting professionals and biohackers focused on cognitive longevity.
Comments (0)
No comments yet. Be the first!